Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury, Deborah Cromer, Arnold Reynaldi, +7

Nature Medicine

Humoral ResponseImmunologyAntiviral ResponseHumoral ImmunityImmune Protection +5

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Sandile Cele, Laurelle Jackson, David S. Khoury, +21

Nature

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19

Adam K. Wheatley, Jennifer A. Juno, Jing Jing Wang, +19

Nature Communications

SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection

Sandile Cele, Laurelle Jackson, David S. Khoury, +21

VaccinationIncomplete EscapePfizer Bnt162b2Viral PersistenceVaccine Development +13

The burden of influenza in England by age and clinical risk group: A statistical analysis to inform vaccine policy

Deborah Cromer, Albert Jan van Hoek, Mark Jit, +3

Journal of Infection

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Sandile Cele, Laurelle Jackson, David S. Khoury, +31

Nature

VaccinationViral EvolutionVaccine DevelopmentPhysicsPositron Annihilation Spectroscopy +12

Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice

Phillip Pymm, Amy Adair, Li‐Jin Chan, +26

Proceedings of the National Academy of Sciences

Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection

David S. Khoury, Timothy E. Schlub, Deborah Cromer, +7

Emerging infectious diseases

VaccinationVaccine SafetyCross-protectionSars-cov-2 InfectionMedicine +11

HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission

Mykola Pinkevych, Deborah Cromer, Martin Tolstrup, +8

PLoS Pathogens

Treatment Interruption OccursViral DynamicHiv RemissionViral PersistenceHiv/aids Counselling +15

Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England

Deborah Cromer, Albert Jan van Hoek, Anthony T. Newall, +2

The Lancet Public Health